Rajiv Patel Insider Profile
4 Followers
Rajiv Patel, Member of a Group Owning 10% at Lantheus, holds 3.48M shares in Lantheus (Ticker: LNTH), holds 2.51M shares in Nexvet Biopharma (Ticker: NVET). Most recently, Rajiv Patel Sold ― shares of Lantheus on Aug 21, 2025 for an estimated value of $191.21M.
Rajiv Patel Lantheus (LNTH)Member of a Group Owning 10%
Lantheus (LNTH)
Member of a Group Owning 10%
Ranked #92,816 out of 108,921 Corporate Insiders
Profitable Transactions
1 out of 5 Profitable Transactions
Average Return
-29.10%
Average return per transaction
Time Frame
Compare to
Insider Roles
Member of a Group Owning 10%
Roles that Rajiv Patel holds in companies
Most Profitable Insider Trade
Stock:
Nexvet Biopharma
(NVET)
(NVET)
Rating:Informative Buy
Date:Oct 02, 2015 - Oct 02, 2016
Return:+1.70%
The most profitable trade made by Rajiv Patel
Rajiv Patel's Trading History
Lantheus
Aug 21, 2025
Member of a Group Owning 10%
Informative Sell
191.21M
$351.10M
Nexvet Biopharma
Aug 02, 2017
―
Uninformative Sell
91.26K
$16.85M
List of latest transactions for each holding click on a transaction to see Rajiv Patel's performance on stock
You May Also Like
Rajiv Patel insider profile FAQ
What is the percentage of profitable transactions made by Rajiv Patel?
The percentage of profitable transactions made by Rajiv Patel is 20%.
What is the average return per transaction made by Rajiv Patel?
The average return per transaction made by Rajiv Patel is -29.10%.
What stocks does Rajiv Patel hold?
Rajiv Patel holds: LNTH, NVET stocks.
What was Rajiv Patel’s latest transaction?
Rajiv Patel latest transaction was an Informative Sell of $191.21M.
What was Rajiv Patel's most profitable transaction?
Rajiv Patel’s most profitable transaction was an Informative Buy of NVET stock on October 2, 2015. The return on the trade was 1.70%.
What is Rajiv Patel's role in Lantheus?
Rajiv Patel's role in Lantheus is Member of a Group Owning 10%.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.